Redesigning the general practice consultation to improve care for patients with multimorbidity

This article illustrates how we are many years from developing any strategies to deal with multimorbidity and polypharmacy. Even if evidence arises for the support of longer consultation times and more cohesive multidisciplinary teams, what will be the financial costs and strain on resources?